Ligand Pharmaceuticals, Inc. (LGND)
237.64
+0.64
(+0.27%)
USD |
NASDAQ |
Jun 08, 14:32
Ligand Pharmaceuticals Shareholders Equity (Quarterly) : 997.32M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Organon & Co. | 903.00M |
| Johnson & Johnson | 81.19B |
| Merck & Co., Inc. | 45.88B |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.532B |
| Total Liabilities (Quarterly) | 534.78M |
| Debt to Equity Ratio | 0.4532 |
| Current Ratio | 21.28 |
| Net Debt Paydown Yield | -2.22% |